Overview

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The main goal of this study is to help answer the following research question(s) and not to treat the child's illness. - Can this study drug make children with bipolar depression feel better? - Does this study drug work better than a placebo (sugar pill)? - Does this study drug cause side effects in children who take it? - Is this drug safe to use in children? (The study drug is a mixture of olanzapine and fluoxetine)
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Fluoxetine
Olanzapine